Teva Pharmaceutical Industries Ltd
Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –
Teva Pharmaceutical Industries Manufacturing & R&D Facilities by Year
Manufacturing & R&D Facilities — International Markets
Teva Pharmaceutical Industries Manufacturing & R&D Facilities: 20 in FY2025, up 5.3% from a year earlier.
Where the FY2025 figure comes from
“|| International Markets | 20 | 5,323”
Source: Form 10-K (0001193125-26-034532) ↗
Reported in SEC Form 10-K (Item 2. Properties).
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Manufacturing & R&D Facilities — International Markets | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20 | +5.3% | Form 10-K (0001193125-26-034532) ↗ |
| FY2024 | Dec 31, 2024 | 19 | +18.8% | Form 10-K (0001193125-25-020826) ↗ |
| FY2023 | Dec 31, 2023 | 16 | -30.4% | Form 10-K (0001193125-24-031005) ↗ |
| FY2022 | Dec 31, 2022 | 23 | -23.3% | Form 10-K (0001193125-23-031250) ↗ |
| FY2021 | Dec 31, 2021 | 30 | -14.3% | Form 10-K (0001193125-22-032667) ↗ |
| FY2020 | Dec 31, 2020 | 35 | -5.4% | Form 10-K (0001193125-21-036239) ↗ |
| FY2019 | Dec 31, 2019 | 37 | -2.6% | Form 10-K (0001193125-20-044221) ↗ |
| FY2018 | Dec 31, 2018 | 38 | 0.0% | Form 10-K (0001193125-19-043564) ↗ |
| FY2017 | Dec 31, 2017 | 38 | – | Form 10-K (0001193125-18-039076) ↗ |
Cite this data
StockData. (2026). Teva Pharmaceutical Industries Manufacturing & R&D Facilities, annual FY2017–FY2025 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/fac-intl-count
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?